Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 57, Issue 2, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.01608-18
Keywords
-
Categories
Funding
- Weill Cornell Medicine from Allergan
- Merck
- bioMerieux
Ask authors/readers for more resources
Polymyxins are relied upon for the treatment of carbapenem-resistant Gram-negative bacterial infections, but polymyxin resistance is increasing. Only broth microdilution is recommended for polymyxin susceptibility testing, but this method is impractical for most clinical microbiology laboratories. An article in this issue of the Journal of Clinical Microbiology (P. J. Simner, Y. Bergman, M. Trejo, A. A. Roberts, R. Marayan, T. Tekle, S. Campeau, A. Kazmi, D. Bell, S. Lewis, P. D. Tamma, R. Humphries, and J. A. Hindler, J Clin Microbiol 57: e01163-18, 2019, https://doi.org/10.1128/JCM.01163-18) found that colistin broth disk elution, a method that requires only colistin disks and broth, had excellent performance compared to broth microdilution for all strains except mcr-positive Escherichia coli strains.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available